Table 2.
Group | n | Infarct volume |
---|---|---|
Sham | 3 | 0.0 ± 0.00 |
CIRU | 3 | 244.3* ± 7.76 |
Scu-50 | 3 | 56.0** ± 2.00 |
Scu-25 | 3 | 74.3∗∗,w ± 3.51 |
Nimodipine | 3 | 98.3** ± 3.06 |
Values are mean ± SD.
*P < 0.01; significantly higher compared with values of sham group.
**P < 0.01; significantly lower compared with values of CIRU group.
w P < 0.01; significantly lower compared with values of Scu-25 group.